tirzepatide patent expiration date us When do the MOUNJARO patents expire, and when will generic MOUNJARO be available? Ozempic's Patent Protection Starts to

Semaglutide vs Tirzepatide: Approved Uses Semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) are medications used to treat type 2 diabetes and chronic weight issues

Both dramatically outperform older medications like phentermine-topiramate (7-9%) and naltrexone-bupropion (4-5%)

Maintain your exercise routine

Among over 500 obese patients with OSAS, long-term tirzepatide treatment led to significant reductions in body weight, AHI, and oxygen desaturation index, with particularly pronounced benefits in patients with concurrent glucose and lipid metabolism abnormalities (52)

Evidence-based ways to optimise results: Maintain a modest calorie deficit (around 500600 kcal/day) Focus on high-protein, high-fibre meals Strength training to preserve muscle mass Daily movement (walking, mobility work, light cardio) Sleep optimisation and stress reduction Rapid weight loss increases the risk of muscle loss, regain and risk of gall bladder issues

Clinical trial results may not reflect real-world outcomes for all patients